ticagrelor
Generic: ticagrelor
Labeler: exelan pharmaceuticals, incDrug Facts
Product Profile
Brand Name
ticagrelor
Generic Name
ticagrelor
Labeler
exelan pharmaceuticals, inc
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
ticagrelor 90 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
76282-550
Product ID
76282-550_62c87369-6ec3-4cd5-82c6-a81c752be6ca
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA208537
Listing Expiration
2026-12-31
Marketing Start
2025-05-07
Pharmacologic Class
Established (EPC)
Mechanism of Action
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
76282550
Hyphenated Format
76282-550
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
ticagrelor (source: ndc)
Generic Name
ticagrelor (source: ndc)
Application Number
ANDA208537 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 90 mg/1
Packaging
- 100 TABLET, FILM COATED in 1 BOTTLE (76282-550-01)
- 500 TABLET, FILM COATED in 1 BOTTLE (76282-550-05)
- 60 TABLET, FILM COATED in 1 BOTTLE (76282-550-60)
Packages (3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "62c87369-6ec3-4cd5-82c6-a81c752be6ca", "openfda": {"nui": ["N0000182142", "N0000008832", "N0000182143", "N0000182141", "N0000185503"], "upc": ["0376282550053", "0376282584010", "0376282584607", "0376282584058", "0376282550015", "0376282550602"], "unii": ["GLH0314RVC"], "rxcui": ["1116635", "1666332"], "spl_set_id": ["eb8fb960-1f0e-40b1-9889-b02296bb3c37"], "pharm_class_pe": ["Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["P2Y12 Platelet Inhibitor [EPC]"], "pharm_class_moa": ["P2Y12 Receptor Antagonists [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["Exelan Pharmaceuticals, Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (76282-550-01)", "package_ndc": "76282-550-01", "marketing_start_date": "20250507"}, {"sample": false, "description": "500 TABLET, FILM COATED in 1 BOTTLE (76282-550-05)", "package_ndc": "76282-550-05", "marketing_start_date": "20250507"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (76282-550-60)", "package_ndc": "76282-550-60", "marketing_start_date": "20250507"}], "brand_name": "TICAGRELOR", "product_id": "76282-550_62c87369-6ec3-4cd5-82c6-a81c752be6ca", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "P-Glycoprotein Inhibitors [MoA]", "P2Y12 Platelet Inhibitor [EPC]", "P2Y12 Receptor Antagonists [MoA]"], "product_ndc": "76282-550", "generic_name": "TICAGRELOR", "labeler_name": "Exelan Pharmaceuticals, Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TICAGRELOR", "active_ingredients": [{"name": "TICAGRELOR", "strength": "90 mg/1"}], "application_number": "ANDA208537", "marketing_category": "ANDA", "marketing_start_date": "20250507", "listing_expiration_date": "20261231"}